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Abstract
Background: Catechol-O-methyltransferase (COMT) is a key enzyme responsible for the degradation of dopamine and
norepinephrine. COMT activity influences cognitive and emotional states in humans and aggression and drug responses in
mice. This study identifies the key sequence variant that leads to differences in Comt mRNA and protein levels among mice,
and that modulates synaptic function and pharmacological and behavioral traits.
Methodology/Principal Findings: We examined Comt expression in multiple tissues in over 100 diverse strains and several
genetic crosses. Differences in expression map back to Comt and are generated by a 230 nt insertion of a B2 short
interspersed element (B2 SINE) in the proximal 39 UTR of Comt in C57BL/6J. This transposon introduces a premature
polyadenylation signal and creates a short 39 UTR isoform. The B2 SINE is shared by a subset of strains, including C57BL/6J,
A/J, BALB/cByJ, and AKR/J, but is absent in others, including DBA/2J, FVB/NJ, SJL/J, and wild subspecies. The short isoform is
associated with increased protein expression in prefrontal cortex and hippocampus relative to the longer ancestral isoform.
The Comt variant causes downstream differences in the expression of genes involved in synaptic function, and also
modulates phenotypes such as dopamine D1 and D2 receptor binding and pharmacological responses to haloperidol.
Conclusions/Significance: We have precisely defined the B2 SINE as the source of variation in Comt and demonstrated that
a transposon in a 39 UTR can alter mRNA isoform use and modulate behavior. The recent fixation of the variant in a subset of
strains may have contributed to the rapid divergence of inbred strains.
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Introduction
Degradation of the catecholamine neurotransmitters dopamine,
epinephrine, and norepinephrine is catalyzed by catechol-O-
methyltransferase (COMT) and the monoamine oxidase enzymes.
The mechanism of transmitter inactivation is distinct for each
enzyme—methylation for COMT and deamination for monamine
oxidase—and the impact each exerts on neurotransmitter tone
varies by brain region. COMT is a key enzyme regulating
dopamine tone in frontal neocortex in which expression is high
relative to the monoamine oxidases and dopamine transporters,
but COMT contributes less to dopamine tone in the striatum and
nucleus accumbens [1,2,3,4]. Dopamine levels play a critical role
in the modulation of cognitive and emotional states, and changes
in dopamine signaling are hallmarks of many psychiatric and
addiction disorders. In humans, non-human primates, and rodents
dopamine levels and cognitive performance have been described
by an inverted U-shaped relation in which too much or too little
extracellular dopamine has detrimental effects [5,6,7].
Multiple SNPs have been identified that lead to changes in
mRNA, protein, and/or activity levels but a single allele (Val108/
158Met) accounts for most of the variation in the level of COMT
activity in humans. Individuals homozygous for the Met allele
have a 3- to 4-fold reduction in COMT activity and increased
prefrontal cortex dopamine levels [8]. Although mice lack this
particular polymorphism, several recent studies have shown that
variation in Comt mRNA level [9] and activity [10] between
C57BL/6J (B6) and DBA/2J (D2) mouse strains is associated with
differences in aggression level and morphine sensitivity, respec-
tively.
The B6 and D2 strains differ greatly on a wide variety of traits
and their genomes are highly polymorphic with approximately 5
million identified sequence variants (www.sanger.ac.uk and www.
genenetwork.org). A genetic reference population of B6 X D2
(BXD) recombinant inbred lines made by crossing these parental
strains has been used extensively to explore differences in gene
expression, neuropharmacology, and behavior, often using
quantitative trait locus (QTL) mapping methods [11,12]. The
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expression of Comt in this family of strains varies over 2-fold in
several CNS regions and is strongly modulated by a polymorphism
located within Comt itself [13]. However, there are no known SNPs
between B6 and D2 in Comt, and the gene is situated in a ,8 Mb
region that is identical by descent among most inbred strains. The
genetic mechanism of the observed variation in Comt expression
has been an unresolved question. In this paper we report the
cloning of the cis sequence variant that controls Comt mRNA
expression in many inbred strains and that produces widespread
effects in the BXD family. The cause of this Comt cis-regulation is
the insertion of a strong and premature polyadenylation signal in
the proximal 39 UTR in B6 and several other strains. As a
consequence these strains produce short 39UTRs compared to
strains without the insertion. This is the first known variant in mice
that causes variation in Comt expression. This mutation has effects
on COMT activity and is clearly linked to downstream variation
in expression of many other genes, dopamine tone, and behavior.
We find both expected and novel biological roles for Comt that are
relevant for the diagnosis and treatment of psychiatric and
cognitive diseases in humans.
Results
Variation in Comt mRNA expression and cis-regulation in
CNS and peripheral tissues
We measured expression of Comt across multiple tissues in over
100 strains of mice and several large F2 intercrosses using four
microrray platforms. Between strains and across tissue we
consistently detect large differences in expression for probe sets
that target both coding exons and the distal 39 UTR (Fig. 1A,
Figure S1, and Figure S2). We mapped this variation in Comt
expression in several crosses, including the large BXD family. In
this family, Comt expression maps to the location of the Comt gene
itself (Fig. 1C and Fig. 1D). Such differences that map back to the
physical location of the gene are referred to as cis-regulated QTLs.
For example in kidney, variation in the distal 39 UTR of the gene
(probe set 1418701_at) maps to chromosome (Chr) 16 with an
extremely high likelihood of the odds (LOD) score of 30 and a 2-
LOD support interval from 17.5 to 19.8 Mb (Fig. 1D). This
demonstrates that sequence variants in or around the Comt gene
control its expression. In this case, each copy of the D2 (D) allele
increases Comt mRNA signal by a factor of two (Fig. 1B and www.
genenetwork.org).
The expression of mRNA containing the distal 39 UTR (probe
set 1418701_at) is strongly cis-modulated in all tissues and is
associated with high expression from the D allele. In contrast,
expression of more proximal coding exons (probe set 1449183_at)
is not as strongly cis-regulated, is more variable across brain
regions and organs, and is usually associated with higher
expression from the B6 (B) allele (Fig. 1B). Mean expression of
the coding exons is higher and less variable among BXD strains
than expression of the distal 39 UTR in all tissues (Fig. 2). For
example, there is over 44-fold variation in distal 39 UTR
expression between the B and D alleles in the kidney compared
to a 4-fold difference in coding exons from the same tissue. The
pattern of high expression from the B allele for more proximal
probe sets and high expression from the D allele for distal 39 UTR
probe sets was replicated in the hippocampus and striatum using
different microarray platforms (Figure S3).
Profound differences in Comt expression were detected among
highly diverse inbred strains of mice (Figure S1, Figure S2). Like
B6, a small number of other common inbred strains, including
129S1/SvImJ, BALB/cByJ, A/J (A), C57BL/6ByJ, and AKR/J
(AK), have low expression using the distal 39 UTR probe set. In
contrast, and like D2, a larger number of strains, including C3H/
HeJ (H), CBA/CaJ, FVB/NJ, KK/HlJ, NZO/HlLtJ, NZW/LacJ,
SJL/J, and all wild subspecies, have high expression. All crosses
derived from strains that differed in Comt expression show strong
cis-modulation. For example, progeny of crosses between B6 and
H, B6 and CAST/EiJ, and AK and D2 demonstrate cis-
modulation whereas progeny of crosses between B6 and A, and
C57BL/6ByJ and BALB/cByJ do not (Table S1).
Collectively, these diverse mapping data sets demonstrate that
expression of Comt is strongly cis-regulated and is caused by
sequence variation in or around Comt itself. Surprisingly, B6, D2,
and the great majority of strains are identical by descent for a large
interval surrounding Comt. There are no known SNPs in Comt
between B6 and D2 (Fig. 3) and only 212 total SNPs between 15
and 23 Mb. The persistence of strong cis-modulation in the
absence of SNPs provided a unique opportunity to identify the
cryptic, but causal sequence variant in Comt.
Sequencing of the Comt locus
Next-generation whole genome sequencing data has recently
been completed for the D2 strain using Applied Biosystems
SOLiD and Illumina GA2 sequencing platforms (whole genome
shotgun coverage of ,52x). A complete compendium of new D2
SNPs and other sequence variants in and around Comt is available
at GeneNetwork (www.genenetwork.org) and from the Wellcome
Trust Sanger Institute (http://www.sanger.ac.uk/resources/
mouse/genomes/). We identified large numbers of structural
variants (copy number variants, translocations, inversions, and
insertions and deletions) between B6 and D2, but none in the Comt
interval. The sole exception was a 230 bp deletion in D2 (Figure
S4). This insertion/deletion (indel) was located in the proximal 39
UTR (Chr 16 from 18,407,621–18,407,392 Mb). We sequenced
the region around the indel in 8 strains with high or low expression
(Fig. 4) and B6 and D2 reciprocal F1 hybrids. The presence or
absence of the indel corresponded to the expression level detected
by the distal 39 UTR probe set (1418701_at). Strains with the
insertion, B6, BXD31, LG/J, and A/J (not shown), have low
expression whereas strains without the insertion, D2, BXD76,
PWK/PhJ, and KK/HIJ (not shown), have high expression.
To rule out the possibility that other sequence variants regulate
Comt we queried genomic sequence data from seventeen inbred
strains available from the Sanger Institute. We found no SNPs,
indels, or haplotypes that segregate with the pattern of expression
for a 62 Mb interval surrounding Comt. The only exception is an
isolated indel that segregates perfectly among all strains with high
or low distal 39 UTR expression. This indel is the only viable
candidate for the massive cis-QTL in Comt. For this reason we
closely examined this variant to understand the mechanisms that
generate the strong cis eQTL.
Characterization of the 39 UTR indel in the comt locus
The 230 bp indel is a repetitive B2 family short interspersed
element (SINE). B2 SINEs are a common type of retro-
transposon representing ,2.4% of the mouse genome [14]. The
B2 sequence contains several typical features, including a split
RNA polymerase III promoter and termination signal. Of
greater significance, this element also contains an array of
overlapping polyadenylation signals flanked by an adenosine (A)
rich segment in the 39 region [15,16,17] (Fig. 5A). The insertion
of this element and several premature polyadenylation sites in a
subset of strains, including B6, should generate mRNA
containing a shorter 39 UTR. In contrast, D2 and other strains
that do not contain the SINE, should use the more distal and
highly conserved polyadenylation site, and therefore produce a
A Recent Mutation in Comt
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longer 39 UTR. We used 39 RACE and RNA sequencing (RNA-
seq) to test the effect of the introduced polyadenylation signal on
39 UTR length. As expected, the B6 strain produced a much
shorter 39 UTR compared to D2 (Fig. 5B) and there was a
marked reduction in mRNA containing the distal 39 UTR in B6
(Figure S5).
Figure 1. Cis modulation of Comt expression by B and D alleles in different tissues. (A) Orientation of probe sets relative to the Comt gene
based on the UCSC Genome Browser Mouse July 2007 Assembly (mm9). Probe sets 1418701_at and 1449183_at are associated with mRNA containing
distal 39 UTR and the last two coding exons and proximal 39 UTR of ComtmRNA, respectively. (B) Cis-modulation of Comt expression visualized using the
QTL heatmap tool available at www.genenetwork.org. Coloration at 18.408 Mb indicates association between genotype at this locus and gene
expression. No color means there is not an association., whereas blue and red shading indicates whether B6 (B) or D2 (D) alleles, respectively, are
associated with higher expression. Yellow arrowheads indicate the physical location of Comt. Among the BXD family theD allele is associatedwith higher
expression of the distal 39 UTR of Comt in all tissues. However, expression of the common codingmRNA probe set is associated with higher expression of
the B allele in whole brain (WB), cerebellum (CER), hippocampus (HIP) and striatum (STR). In the kidney (KID) and the prefrontal cortex (PFC), expression
of coding Comt mRNA is also associated with higher expression of the D allele. (C) Multiple QTL maps for Comt coding exons. Strong cis-regulation of
expression is observed for all tissues except for the EYE (eye), VTA (ventral tegmental area), and NAC (nucleus accumbens). Purple arrowheads indicate
the approximate location of Comt. (D) Multiple QTL maps for Comt distal 39 UTR. Significant cis-regulation of Comt is observed across all tissues.
doi:10.1371/journal.pone.0012181.g001
A Recent Mutation in Comt
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The insertion of the B2 SINE produces variation in 39 UTR
length that segregates among BXD strains and is the sole cause of
cis-regulation of Comt expression. In the BXD panel, probe set
measurements based on the distal 39 UTR detect the presence or
absence of the long 39 UTR isoform and show consistent allelic
regulation of expression (Figure S1, Figure S2). Probe sets that
target coding exons do not discriminate between isoforms and
more accurately reflect overall strain and tissue differences in total
mRNA level. The genetic control of these probe sets was tissue
specific. For example, highest expression of coding exons in the
cerebellum, hippocampus, and striatum was associated with the B
allele, whereas in prefrontal cortex and kidney, higher expression
was generally associated with the D allele (Fig. 1B and Fig. 2). This
demonstrates that transacting factors and tissue specific trans-
QTLs are also important modulators of Comt expression.
Independent of variation in total Comt levels, strains with the B2
SINE insertion primarily produce Comt with a short 39 UTR and
strains without the insertion produce Comt with a long 39 UTR. It
is possible that these differences in 39 UTR length have a
functional consequence on protein level. In rodent brain a single
transcript codes for both soluble (S-) and membrane bound (MB-)
COMT through a leaky scanning mechanism [18]. We compared
the level of both protein isoforms between strains in hippocampus
and prefrontal cortex and both are expressed more highly in B6
(Fig. 6). Regardless of relative mRNA abundance between strains,
B6 mRNA containing the shorter 39 UTR is associated with
higher levels of COMT protein expression.
Impact of Comt gene sequence variation on downstream
biological functions
What sets of higher order phenotypes are downstream of the
Comt polymorphism? To answer this question we extracted all
classical phenotypes in the GeneNetwork BXD phenotype
database that map within 2 Mb of Comt. The prior probability
of mapping near Comt is unusually low because this region is small
(0.16% of the genome) and, with the exception of the B2 SINE
polymorphism, is identical by descent (Fig. 3). Even in massive
expression data sets no more than 1–2 transcripts are expected to
map to this region by chance. Twelve classical phenotypes with
high content validity map to the Comt locus (p,0.02, Table S2),
including binding affinity of both dopamine receptors (DRD1 and
DRD2) in caudate, nucleus accumbens, ventral tegmental area,
Figure 2. Expression of Comt coding exon and distal 39 UTR in the BXD population across tissues. Probe sets representing either coding
exon or distal 39 UTR were used to measure Comt expression in parental and BXD strains. Strain allelic expression for both Comt probe sets was
determined based on the genotype (B6 or D2) of nearby marker rs4165069 (located on chromosome 16 at 17.577 Mb). Average expression for B6 (B)
and D2 alleles (D) was determined for each probe set across tissues. (Top panel)There is less variation between alleles for Comt exon expression across
multiple tissues as assayed by probe set 1449183_at. (Bottom Panel) In contrast, there is much greater variation when assayed using the distal 39UTR
(1418701_at). Higher expression of the distal 39 UTR is consistently associated with the D allele while higher expression is associated with the B allele
for Comt coding exons in the whole brain (WB), cerebellum (CER), hippocampus (HIP), and striatum (STR). Higher expression of coding exons is
associated with the D allele in the prefrontal cortex (PFC). Expression of coding exons in the ventral tegmental area (VTA), nucleus accumbens (NAC),
eye (EYE), and kidney (KID) is not strongly dependent on genotype.
doi:10.1371/journal.pone.0012181.g002
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and prefrontal cortex [19]. Linkage of DRD1 and DRD2 binding
was sex-specific and only detected in males. Sensitivity to the
dopamine receptor antagonist haloperidol [20] and chloradiazep-
oxide, an allosteric modulator of GABA-A receptors [21], also
map to Comt.
To explore intermediate networks between Comt and the classic
phenotypes listed above, we extracted transcripts modulated by
Comt in four brain regions (Fig. 7, Table S3). Transcripts and genes
with trans QTLs mapping into the Comt locus were filtered by
expression level, biological relevance, and by examining expres-
sion in the Allen Institute for Brain Science (AIBS) brain atlas
(www.brain-map.org). Downstream targets of Comt participate in
cytoskeletal regulation (Cmip, Etnk1, and Ptprd), intracellular
signaling (Cdc42, Araf, Hipk2, Cmip, Etnk1, Ptprd, and Rasgrp1),
transport (Stau1, Adam10, Dnajc10, Mcoln1, Golga3, Arl7, Spo, Pitpnb,
Ddx47, Capns1, and Kif5a), receptor/channel trafficking (Palm,
Akap9, Sqstm1, Cntn2, Nsg1, and Dlgap1), synaptic maintenance and
plasticity (Apba1, Tle3, Slit3, Slc12a6, Elavl4, and Syt1), transcrip-
tional regulation (Nipbl, Myt1l, Ncor1, Jundm2, and Tef), and
catecholamine metabolism (Maoa). Given the marked differences
in expression of Comt covariates in different tissues and organs, we
neither expected nor did we find significant overlap of its
downstream targets. One exception was receptor protein tyrosine
phosphatase delta (Ptprd). A key signaling molecule in the CNS
Figure 3. C57BL/6J and DBA/2J are identical by descent for a large region on chromosome 16 surrounding Comt. (A) Next-generation
sequencing (red) reveals previously unknown SNPs between B6 and D2. The original SNP panel (blue) was obtained at www.ncbi.nlm.nih.gov/
projects/SNP/. A large interval surrounding Comt from ,15 to 23 Mb is devoid of SNPs. (B) There are no known SNPs between B6 and D2.
doi:10.1371/journal.pone.0012181.g003
A Recent Mutation in Comt
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involved in neurite growth [22], deletion of Ptprd leads to learning
and feeding impairments, in addition to alterations in hippocam-
pal long-term potentiation [23]. There was significant overlap in
gene function across data sets. Well supported categories included
receptor trafficking, and synaptic maintenance/plasticity. Each
region also included key genes associated with addiction (Maoa,
Ptprd, and Slit3), psychiatric illnesses (Maoa, Myt1l, Slc12a6, and
Slit3), and neurodegenerative diseases (Apba1 and Slc12a6).
Discussion
In this study we have identified the sequence variant underlying
a strong cis-acting expression quantitative trait locus (eQTL) for
the Comt gene. Comt is located in a large interval that is otherwise
devoid of sequence variants between the BXD strains. In
combination with strong mapping data, this provides definitive
genetic and sequence support that the insertion of the B2 SINE
into the proximal 39 UTR is the ultimate cause of the Comt eQTL.
Based on expression data and corroborative sequence data, wild
derived strains (MOLF/EiJ, CAST/EiJ, PWK/PhJ, and PWD/
PhJ) and Swiss mice (FVB/NJ and SJL/J) lack the insertion. Some
strains derived from W. E. Castle and C. C. Little’s stocks contain
the insertion (C57BL/6J, A/J, 129S1/SvlmJ, and BALB/cByJ)
whereas others do not (DBA/2J, 129P3/J, CBA/J, and C58/J). In
the absence of the B2 SINE, inbred strains produce mRNA with a
long 39 UTR. The insertion introduces a premature polyadenyl-
ation site and the production of a short isoform. The propagation
of the B2 SINE in several strains derived by Castle and Little, as
well as its absence in wild derived strains, is evidence that the long
39 UTR is ancestral. The short isoform is likely the result of a
transposition fixed by inbreeding in the early 1900s. This naturally
occurring mutation is likely to be the major source of variation in
Comt expression among inbred strains.
The B2 SINE is associated with higher expression of Comt
coding exons in B6 relative to D2 in the cerebellum, hippocampus,
and striatum but not in the prefrontal cortex, ventral tegmental
area, and nucleus accumbens. The B2 SINE insertion accounts for
over 90% of the variance in mRNA length and expression across
tissues but it is not the only mechanism governing expression.
Approximately 50% of the variance of the common coding form is
due to segregating trans-effects, non-segregating masking epistatic
Figure 4. A 230 bp insertion in the proximal 39 UTR of Comt is
present in multiple strains. PCR amplification of genomic DNA using
primers flanking the 39UTR (18,407,151 to 18,407,758 Mb) generates
two different products. Strains containing the B2 SINE, such as B6,
generate a larger PCR product (approximately 600 bp) then do strains
lacking the SINE, such as D2 (approximately 400 bp). Genomic DNA
from reciprocal hybrids (B6D2F1 and D2B6F1), which are heterozygous
for the B2 SINE indel, generates both a short and long product due to
inheritance of both B6 and D2 alleles, respectively.
doi:10.1371/journal.pone.0012181.g004
Figure 5. Insertion of a B2 SINE containing an alternative polyadenylation site into the Comt gene leads to the production of mRNA
containing a shorter 39 UTR in B6. (A) Gel electrophoresis of 39 RACE products shows that D2 produces mRNA containing a 39 UTR that is
,200 nts longer compared to B6. This is consistent with the truncation of B6 mRNA due to the introduction of the B2 SINE polyadenylation signal (A).
Expression data indicate that a small amount of the long 39 UTR produced in most tissues of strains with the insertion, likely due to read-through of
the B2 SINE polyadenylation signal. (B) Black shaded text indicates identical proximal 39 UTR DNA sequence in B6 and D2 strains. Bold text and grey
shaded text indicate the position of a poly (A) tail and polyadenylation signals, respectively. The B2 SINE (sequence in center box) contains both A
and B box RNA polymerase III promoters (asterisks and underlined text, respectively), a consensus RNA polymerase III termination signal (underlined
text), a polyadenylation signal arranged in an overlapping array (bold text, shaded in grey), and an adenine- (A-) rich 39 flanking region (bold text).
Arrows indicate the approximate position of both a custom Comt forward primer (right arrow) and a generic reverse primer (left arrow) used to
amplify 39 RACE products from cDNA for each strain. The exact length of the poly-A tail for each mRNA species from B6 and D2 is not known.
Genomic positions based on the B6 reference strain (UCSC Genome Browser on Mouse July 2007 Assembly mm9).
doi:10.1371/journal.pone.0012181.g005
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interactions, and residual error. Intriguingly, our protein analysis
reveals that mRNA containing the short 39 UTR is translated at a
higher level than mRNA containing the longer 39 UTR, regardless
of relative isoform abundance in different tissues. This effect may
be mediated by differences in secondary structure between
isoforms, preferential binding to each isoform by factors regulating
transport or translation, or by isoform differences in polyadenyl-
ation. The net result however is that the B2 SINE, by causing a
change in the length of the 39 UTR, contributes significantly to
genetic variation in COMT protein abundance. An increase in
total COMT could be associated with higher enzymatic activity
and previous research has demonstrated significantly higher
COMT activity in the nucleus accumbens and prefrontal cortex
of the B6 strain compared to D2 [10]. These results demonstrate a
link between genomic sequence variation, transcript abundance,
protein level, and enzymatic activity.
Variation in Comt message and protein levels caused by the B2
SINE influences multiple neurotransmitter systems, and has
known and novel downstream effects on neuronal signaling and
behavior (Fig. 7). Key genes regulated by Comt are involved in
catecholamine metabolism (Maoa), nervous system maintenance
(Slc12a6), the excitatory postsynaptic density (Dlgap2), and receptor
trafficking of AMPA (Palm, Sqstm1, and Nsg1) and NMDA (Akap9
and Apba1) receptors. The Comt downstream network also
modulates synaptic transport (Stau1, Elavl4, Kif5a, and Syt1) and
intracellular signaling (Hipk2, Araf, Cmip, and Etnk1). As expected,
dopaminergic systems are clearly downstream of Comt, including
Maoa in the striatum, DRD1 and DRD2 binding density in
multiple brain regions, and the response to the dopamine receptor
antagonist haloperidol. Finally, Comt modulates components of the
glutamatergic and GABAergic systems and is linked to the
expression of genes involved in excitatory synapse maintenance
and locomotor responses to chlordiazepoxide, an allosteric
modulator of GABA-A receptors.
The Comt variant exposes interconnectivity among neurotransmit-
ter systems. From one perspective this may be surprising given the
role of this enzyme in catecholamine catabolism, but even small
changes at the end of a biochemical cascade feed back on transmitter
synthesis and receptor trafficking to maintain homeostasis. Polymor-
phisms in COMT are often associated with CNS diseases such as
schizophrenia, anorexia nervosa, bipolar disorder, anxiety, and
substance use disorders [24]. These complex diseases have
comparatively high genetic complexity, population heterogeneity,
overlapping diagnostic criteria, modest additive effects of single
polymorphisms, and a high likelihood that epistatic interactions
influence disease risk [25,26,27,28,29]. The more widespread use of
joint studies of mouse and human populations will provide an
effective translational bridge. Genes and pathways that we have
identified as sensitive to Comt variation in mice are attractive
candidates in humans. Similarly, genes and pathways identified in
human families and genome-wide association studies are attractive
candidates to study using mouse reference populations.
There is significant divergence in COMT sequence and activity
between mice and humans. A more efficient first initiation site in
human COMT mRNA leads to the production of more
membrane bound MB-COMT than soluble S-COMT in human
brain [30] which, despite having a lower enzyme capacity, has a
higher affinity for dopamine and other neurotransmitters
[31,32,33]. In contrast, mice express both protein isoforms
abundantly in brain. In humans multiple SNPs have been
identified that lead to changes in mRNA, protein, and enzyme
activity. In contrast, common strains of mice have little variation in
Comt sequence, the B2 SINE, excepted. Additionally, mouse
COMT, which contains Leu instead of Val at the equivalent
position as the human Val108/158Met polymorphism, has higher
activity than the Val allele [8]. In fact, amino acid substitution
from Leu in mice to Val in monkeys and Met in humans
substantially reduces COMT activity. This results in increased
brain dopamine signaling in humans with important cognitive
consequences. For example, Met polymorphisms, which decrease
COMT activity, enhance working memory and attention
[5,34,35,36,37,38,39]. However, the Met allele is associated with
less pain and stress resiliency compared to the Val allele [40].
Despite the differences in the genetic regulation of Comt between
mouse and human, manipulations point to very similar roles in
cognition and behavior. Consistent with human studies, disruption
of Comt in male mice elevates dopamine levels in the prefrontal
cortex [2] and enhances working memory [30]. Conversely,
overexpression of human COMT containing the Val polymor-
phism in mice leads to the disruption of working memory and
attention and a reduction in sensitivity to pain and stress [30].
Mammalian genomes contain a large proportion of transpos-
able elements (TEs), including the Alu family of SINEs in humans,
and B1 and B2 SINEs in rodents. TE insertions, such as the B2
SINE in Comt, are important drivers of gene evolution [16,41].
Approximately 7% of genes in mice contain non-conserved
polyadenylation sites derived from TEs [41]. These polyadenlya-
tion sites can be co-opted to create novel mRNA structures that
effect message processing, distribution, and translation. As in the
case of Comt, insertion of a B2 SINE in the 39 UTR of major
histocompatibility complex genes results in preferential usage of a
premature polyadenylation signal [15]. Given the abundance of
B1 and B2 SINES—564,000 and 348,000 copies, respectively
[14]—it is highly likely that insertions of TEs modulate the
expression of several other genes. These types of mutations,
combined with intense selection, may have contributed to the
rapid behavioral evolution of both wild populations and laboratory
strains [42].
Figure 6. The level of COMT protein differs between the B6 and
D2 strains. Lanes 1 through 3 and 4 through 6 represent biological
replicates from B6 and D2, respectively. Upper and lower panels show
protein levels in the prefrontal cortex and hippocampus, respectively.
Actin levels are measured as a loading control. Two protein isoforms of
COMT are expressed in mice and recognized by the COMT antibody; the
longer membrane bound (MB)-COMT and the smaller soluble (S)-COMT.
Both isoforms have higher expression in B6 compared to D2 in the
prefrontal cortex (PFC) and hippocampus (HIP). Based on the amount of
actin detected in the hippocampus it appears that there may be a slightly
higher amount of protein in the D2 samples, however, the expression of
MB-COMT and S-COMT is still higher in B6 compared to D2.
doi:10.1371/journal.pone.0012181.g006
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Methods
Ethics statement
All animal work was conducted according to an approved animal
use protocol (UTHSC680) and in accordance with procedures
approved by the Institutional Animal Care and Use Committee.
Expression and QTL analysis of Comt using GeneNetwork
Multiple expression datasets from many brain and peripheral
tissues of inbred and RI strains were used in this analysis (see Text S1
for additional methods). Additional detailed descriptions of strain, sex,
tissue preparation and microarray method for each individual
database is available at www.genenetwork.org. Four microarray
platforms were used in this analysis including; Agilent, Illumina,
Affymetrix Exon 1.0 ST, and M430 arrays. Tools for QTL mapping
and visualization are available at www.genenetwork.org [43,44].
Comt 39 UTR genomic DNA isolation and sequencing
Mice were purchased from Jackson Laboratory or bred in-
house. Mice were housed at the University of Tennessee Health
Science Center in a pathogen-free colony in accordance with
procedures approved by the Institutional Animal Care and Use
Committee. Naive B6, D2, BXD31, BXD76, B6D2F1, D2B6F1,
A/J, LG/J, PWK/PhJ, and KK/HlJ mice were killed at about 60
days of age by cervical dislocation.The liver was immediately
collected and stored in RNALater (Ambion) at 4uC overnight.
Genomic DNA was isolated using DNeasy Kits (QIAGEN) We
used Primer 3 software to design custom forward (59-GCG CCA
TCA TAC CTG AAA AG-39) and reverse (59-GGA AAA CAC
CTG TGC ATCA A-39) primers specifically targeting Comt 39
UTR genomic DNA for amplification by PCR. PCR product size
was predicted to be 608 bp based on available genomic data for
the B6 reference strain. Coverage area within the Comt locus was
from 18,407,151 to 18,407,758 Mb. DNA amplification was
performed using the HotStar HiFidelity Polymerase kit (Qiagen)
and 10 ng of genomic DNA for each strain followed by sequencing
of the PCR products with each custom primer using an A3130XL
Genetic Analyzer (Applied Biosystems). The resulting sequences
were aligned against reference sequences from the NCBI GenBank
database using nucleotide blast. The sequences were also aligned
Figure 7. Comt regulatory model. Insertion of a B2 SINE causes 39 UTR length isoforms with important functional consequences. Two concentric
rings show the downstream effect Comt sequence variation has on the gene expression (white ring) and phenotypes (yellow ring). Variation in Comt
influences several neurotransmitter systems, including GABA and dopamine, and modulates the expression of genes involved in numerous biological
processes, including receptor trafficking at excitatory synapses (Palm, Sqstm1, Nsg1, Akap9, and Apba1).
doi:10.1371/journal.pone.0012181.g007
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between strains using BLAST (bl2seq). The genomic DNA
sequence of the Comt 39 UTR for the D2 strain is available at
GenBank (GU324996).
Expression analysis using RNA -seq
Total RNA was isolated from the whole brains of 27BXD RI
strains using RNA STAT-60 (Tel-Test Inc). Samples were DNase
treated using a DNA-free kit (Ambion) to eliminate genomic DNA.
The quality and purity of total RNA from each sample was
assessed using an Agilent Bioanalyzer 2100 system. For RNA-seq,
ribosomal RNA (rRNA) was removed from each total RNA
sample using the RiboMinus Eukaryote Kit (Invitrogen). Each
RNA sample was then converted to cDNA and amplified.
Emulsion PCR was performed for each sample and each fragment
library was subsequently sequenced on the Applied Biosystems
SOLiD platform. This procedure preserves the strandedness (plus
or minus) of the RNA read.
RNA-seq data processing and visualization
Short sequence reads were analyzed using Applied Biosystems
whole transcriptome software tools (www.solidsoftwaretools.com/).
Reads were mapped to the B6 reference genome (mm9, US
National Center for Biotechnology Information (NCBI) build 37)
with a minimum alignment score of 24.
Isolation and sequencing of Comt 39 UTR mRNA
RNA STAT-60 (Tel-Test Inc) was used for RNA extraction
from B6 and D2 hippocampus followed by ethanol precipitation.
RNA quality was determined using a NanoDrop spectrophotom-
eter (Thermo Scientific) and Agilent Bioanalyzer 2100 (Agilent).
Target cDNA was generated using the FirstChoice RLM-RACE
kit (Ambion) with minor modifications to the standard protocol
(Text S1). The amplified products for each strain were purified
with a PCR purification kit (Qiagen) and sequenced using both
Comt 39 UTR forward primer and the 39 RACE inner primer
separately. The mRNA sequence data for the B6 and D2 strain is
available at GenBank (GU324998 contains B6 39 UTR mRNA
sequence and GU324997 contains D2 39 UTR mRNA sequence).
The full length of the 39 UTR is 553 and 789 nt for the B6 and D2
strain, respectively.
Protein extraction and immunoblotting
Fresh brain tissue from the hippocampus and prefrontal cortex
was dissected from B6 and D2, snap-frozen in liquid nitrogen, and
stored at280uC followed by protein extraction (Text S1). Aliquots
were created from each total protein extract and stored at 280uC
until used for immunoblotting. Six total protein samples each from
the hippocampus and prefrontal cortex of the B6 and D2 strain
were used. Fifteen ug of protein was loaded on a NuPAGE
4212% Bis-Tris Gel (Invitrogen). Protein samples were separated
by electrophoresis at 150 volts for 45 min before transferring to a
PVDF membrane. Immunoblotting was performed using the
WesternDot 625 goat anti-mouse Western blot kit (Invitrogen)
according to the manufacturer’s instructions (Text S1). Primary
antibodies used in immunoblotting were mouse anti-COMT
(clone 4/COMT, aa 26–141) and mouse anti-actin Ab5 (BD
Transduction Laboratories). Images were acquired with an
AlphaImager HP (Alpha Innotec).
Mapping traits to the Comt locus
We used a point-wise p-value of ,0.02 (LOD.1.73) to identify
traits downstream of Comt. Phenotypes within the BXD Phenotype
database were correlated with marker rs4165069 followed by
marker regression to select traits with a significant marker
association. Probe sets mapping to Comt were identified using the
advanced search option in GeneNetwork across several Affymetrix
M430 and Exon brain databases (Text S1). The advanced search
option was used to detect probe sets with at least an LRS of 8
(LOD.1.73; p,0.02) and a mean expression level of 8 and 11 in
the M430 and exon databases, respectively. False discovery rates
for eQTL were conditioned by the likelihood that traits would
map near Comt based on a target interval of 4 Mb and the relative
density of sequence variants that produce eQTLs. Given these
priors we expected less than 2 trans eQTL would map to the Comt
interval by chance. Out of 24, 60, 18, and 30 probe sets mapping
to the Comt locus in the hippocampus, striatum, prefrontal cortex
and nucleus accumbens, respectively, we used our filtering criteria
to select the 10 strongest traits controlled by variation in Comt from
each region. Top probe sets were selected based on probe set
specificity, strength of association to the Comt locus, biological
function, and expression pattern for each relevant brain region in
the AIBS (www.brain-map.org).
Supporting Information
Figure S1 Strain variation in expression of distal 39UTR Comt
mRNA in whole brain and hippocampus. Mean log 2 expression
values depicted above on the y-axis are from the UCHSC BXD
Whole Brain M430 2.0 (Nov06) RMA database and the
Hippocampus Consortium M430v2 (Jun06) RMA. Strains are
indicated by the x-axis. Average expression across databases is 8
log2 units. Arrows indicate parental strains and numbers indicate
recombinant inbred line (e.g. 40=BXD40). (A) Both BXD and
other inbred strains separate into two expression groups with
either B6-like low expression or D2-like high expression of Comt
mRNA containing distal 39UTR sequence in the whole brain. (B)
The same pattern of expression is observed in the hippocampus for
BXD and other inbred strains. BXD and CXB parental strains are
designated by the red and black arrows, respectively. When strains
that share the same distal 39 UTR mRNA expression pattern are
crossed, as in the CXB strains (C57BL/6ByJ x BALB/cByJ), no
expression differences are observed.
Found at: doi:10.1371/journal.pone.0012181.s001 (0.56 MB TIF)
Figure S2 Strain variation in expression of coding exon Comt
mRNA (1449183_at) in whole brain and hippocampus. Mean
log 2 strain expression values are shown on the y-axis from the (A)
UCHSC BXD Whole Brain M430 2.0 (Nov06) RMA database
and the (B) Hippocampus Consortium M430v2 (Jun06) RMA.
Strains are identified on the x-axis. Average expression across
databases is 8. Individual BXD lines are identified by a number
only (e.g., 16=BXD16). There is a wide range of strain variation
in the expression of coding exon mRNA which detects all
expressed isoforms of Comt mRNA. Although there are high and
low expressing strains, segregation into two distinct expression
groups is not as readily apparent as was observed for the
expression of the distal 39 UTR. Black and red arrows indicate
parental strains for the BXD and CXB strains (C57BL/6By x
BALB/cBy), respectively.
Found at: doi:10.1371/journal.pone.0012181.s002 (0.68 MB TIF)
Figure S3 Replication of Comt expression and genetic regulation
in the hippocampus using Affymetrix Exon 1.0 ST arrays. (A)
Location of probe sets to the distal 39 UTR (4989545) and the last
exon (5131400) of Comt based on BLAT search in the UCSC
Genome Browser Mouse July 2007 Assembly (mm9). (B) Both
probe sets are strongly cis-regulated from a region on chromosome
16 near the physical location of the Comt gene. (C) The B allele
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drives expression of the last exon while the D allele drives
expression of the distal 39 UTR.
Found at: doi:10.1371/journal.pone.0012181.s003 (0.28 MB TIF)
Figure S4 Sequence alignment of C57BL/6J (B6) and DBA/2J
(D2) genomic DNA in the chromosome 16 region containing the
indel. There is a 230 bp insertion in the B6 strain, absent in the
D2 strain. Red and black indicate genomic sequence from the D2
and B6, respectively. The corresponding genomic position is based
on the (-) strand for the B6 reference strain. Dashes indicate the
indel position.
Found at: doi:10.1371/journal.pone.0012181.s004 (0.24 MB TIF)
Figure S5 Validation of the effect of the B2 SINE insertion on
distal 39 UTR expression by RNA-seq. RNA sequencing was
performed on whole brain samples from 27 BXD strains as
described in the methods. Strains were subdivided into a B or D
allele group for the Comt locus based on genotype at marker
rs4165081. The B allele group included 10 strains and the D allele
group included17 strains. The Comt locus was subdivided into six
features and the total number of 50-nt sequence tags mapping to
each feature was determined for all strains. Tag counts were
normalized by dividing by the total number per million in each
sample. Normalized tag counts are shown for the B and D allele
for each feature. A t-test revealed a significant difference between
the B and D allele for the distal 39 UTR (p= 0.015; **) and the
second to last coding exon (p= 0.044; *). No sequence tags map
exclusively to the B2 SINE because it is a repetitive element and
similar sequences are scattered throughout the genome.
Found at: doi:10.1371/journal.pone.0012181.s005 (0.13 MB TIF)
Table S1 Summary of Comt regulation.
Found at: doi:10.1371/journal.pone.0012181.s006 (0.03 MB
DOC)
Table S2 Published phenotypes mapping to the Comt locus.
Found at: doi:10.1371/journal.pone.0012181.s007 (0.04 MB
DOC)
Table S3 BXD exon and M430 top probe sets mapping to the
Comt locus.
Found at: doi:10.1371/journal.pone.0012181.s008 (0.26 MB
DOC)
Text S1 Supplemental methods.
Found at: doi:10.1371/journal.pone.0012181.s009 (0.07 MB
DOC)
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